Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome
- 19 August 2005
- journal article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 35 (2) , 179-184
- https://doi.org/10.1016/j.jcv.2005.07.005
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- An interferon‐γ‐related cytokine storm in SARS patientsJournal of Medical Virology, 2004
- Natural Course of Severe Acute Respiratory Syndrome–Associated Coronavirus Immunoglobulin after InfectionThe Journal of Infectious Diseases, 2004
- Neutralizing Antibodies in Patients with Severe Acute Respiratory Syndrome-Associated Coronavirus InfectionThe Journal of Infectious Diseases, 2004
- Longitudinal Profile of Immunoglobulin G (IgG), IgM, and IgA Antibodies against the Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein in Patients with Pneumonia Due to the SARS CoronavirusClinical and Vaccine Immunology, 2004
- Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patientsClinical Microbiology & Infection, 2004
- Serology of Severe Acute Respiratory Syndrome: Implications for Surveillance and OutcomeThe Journal of Infectious Diseases, 2004
- The Severe Acute Respiratory SyndromeNew England Journal of Medicine, 2003
- Microbiologic Characteristics, Serologic Responses, and Clinical Manifestations in Severe Acute Respiratory Syndrome, Taiwan1Emerging Infectious Diseases, 2003
- Profile of Specific Antibodies to the SARS-Associated CoronavirusNew England Journal of Medicine, 2003
- Changes in levels of anti‐dengue virus IgG subclasses in patients with disease of varying severityJournal of Medical Virology, 1993